Nexalin (NXL) Files Form 144 for 23,150-Share Sale via Ladenburg

Rhea-AI Filing Summary

Nexalin Technology, Inc. (NXL) filed a Form 144 notice reporting a proposed sale of 23,150 shares of an "Other" class of securities to be executed through Ladenburg Thalmann & Co. Inc. on the NASDAQ with an approximate sale date of 09/10/2025. The filing lists the number of shares outstanding as 1,718,000 and an aggregate market value of 402.81 (as reported). The shares were acquired on 09/16/2022 in an open market purchase from Maxim Group, with payment recorded as cash/check. The filer indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Compliance Officer

TL;DR: Routine Rule 144 sale notice documenting a proposed sale through a broker with necessary acquisition and payment details.

The Form 144 provides the procedural details required under Rule 144: the class, broker, sale date, shares to be sold, acquisition date and method, source of shares, and payment form. It also confirms no reported sales in the prior three months and includes the standard attestation regarding undisclosed material information. From a compliance perspective, the filing appears to cover the required fields for a notice of proposed sale; further review would verify eligibility under Rule 144 holding periods and any aggregation requirements.

Equity Research Analyst

TL;DR: Insider/affiliate notified intention to sell 23,150 shares; data shows size relative to total outstanding shares.

The notice quantifies the proposed sale at 23,150 shares against 1,718,000 outstanding, providing investors with a sense of scale. The reported aggregate market value (402.81) is included as stated in the filing. Because this is a notice of intent rather than an executed trade, it is informational; investors often monitor such filings to track potential future supply. The filing does not include revenue, earnings, or other operational metrics, so its direct financial impact cannot be assessed from this document alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Other	Ladenburg Thalmann & CO Inc 640 5ht ave, 4th floor New York NY 10019	23150	402.81	1718000	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Other	09/16/2022	Open Market Purchase	Maxim Group			23150	09/16/2022	cash/check

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)